The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Abstract Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a
“liquid biopsy” approach and as a source of valuable tumor markers. CTCs are rare, and …

Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that
originate from the primary tumor or metastatic sites. New techniques have been developed …

Circulating tumor cells (CTCs) may be detected in the blood of patients with epithelial tumors
using different analytical approaches. The relative number of CTCs is low and they include a …

The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Circulating tumor cells (CTCs) are cells derived from the primary sites of tumor patients into
peripheral blood and serve as seeds that initiate tumor metastasis to distant sites. As a …

Circulating tumor cells (CTCs) can be separated and characterized from normal
hematopoietic cellular constituents by a variety of methods. Different strategies have …

It is believed that the development of metastatic cancer requires the presence of circulating
tumor cells (CTCs), which are found in a patient's circulation as rare abnormal cells …

Circulating tumor cells (CTCs) are rare cancer cells released from tumors into the
bloodstream that are thought to have a key role in cancer metastasis. The presence of CTCs …